Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands

[This corrects the article DOI: 10.3389/fimmu.2021.811351.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2022-12, Vol.13, p.1095038-1095038
Hauptverfasser: Probert, Fay, Yeo, Tianrong, Zhou, Yifan, Sealey, Megan, Arora, Siddharth, Palace, Jacqueline, Claridge, Timothy D W, Hillenbrand, Rainer, Oechtering, Johanna, Kuhle, Jens, Leppert, David, Anthony, Daniel C
Format: Artikel
Sprache:eng
Schlagworte:
biomarker
diagnosis
Immunology
metabolomics (OMICS)
multiple sclerosis (MS)
oligoclonal band
proteomics
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[This corrects the article DOI: 10.3389/fimmu.2021.811351.].
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.1095038